Skip to main content
. 2022 Mar 14;12:101. doi: 10.1038/s41398-022-01847-8

Fig. 2. Medication congruency by week in the Per-Protocol cohort of the GAPP-MDD clinical trial and the previous GUIDED trial [14].

Fig. 2

The proportion of patients taking genetically congruent medications from the GAPP-MDD and GUIDED trials are shown in blue and orange, respectively. Squares represent Guided-Care treatment arms, and circles represent TAU treatment arms.